tiprankstipranks
Trending News
More News >
Active Biotech AB (SE:ACTI)
:ACTI
Sweden Market

Active Biotech AB (ACTI) Income Statement

Compare
0 Followers

Active Biotech AB Income Statement

Last quarter (Q4 2024), Active Biotech AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Active Biotech AB's net income was kr-10.20M. See Active Biotech AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 6.72M
Gross Profit
kr 0.00kr -1.68Mkr -1.49Mkr -1.28Mkr 6.72M
Operating Expenses
kr 39.80Mkr 46.50Mkr 57.89Mkr 49.78Mkr 39.03M
Depreciation and Amortization
kr -100.00Kkr 1.68Mkr 1.49Mkr 1.28Mkr 1.32M
EBITDA
kr -39.90Mkr -43.89Mkr -56.67Mkr -48.52Mkr -30.84M
Operating Income
kr -39.80Mkr -46.48Mkr -57.89Mkr -49.78Mkr -32.31M
Other Income/Expenses
kr 400.00Kkr 684.00Kkr -486.00Kkr -43.00Kkr 61.00K
Pretax Income
kr -39.40Mkr -45.80Mkr -58.37Mkr -49.83Mkr -32.24M
Net Income
kr -39.40Mkr -45.80Mkr -58.69Mkr -49.88Mkr -32.12M
Per Share Metrics
Basic EPS
kr -0.09kr -0.17kr -0.23kr -0.20kr -0.19
Diluted EPS
kr -0.09kr -0.17kr -0.23kr -0.20kr -0.19
Weighted Average Shares Outstanding
420.43M 269.41M 260.04M 245.66M 168.37M
Weighted Average Shares Outstanding (Diluted)
420.43M 271.52M 260.04M 245.66M 168.37M
Currency in SEK

Active Biotech AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis